Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CALIX LIMITED Director's Dealing 2022

Oct 24, 2022

64736_rns_2022-10-24_41c46e8a-6d46-4c21-bafa-7b701ddcda92.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [596 x 68] intentionally omitted <==

25 October 2022

Updates to 3Y notices for Phil Hodgson and Mark Sceats

Sydney, Australia | 25 October 2022 – Australian environmental technology company, Calix Limited (ASX: CXL) (“Calix” or the “Company”) confirms today the completion of an off-market selldown of a minor proportion of two Director’s shareholdings. The selldown was previously announced on 19 October 2022, as part of an institutional Placement (“Placement”) to raise $60m to accelerate commercialisation of Calix’s industrial decarbonisation technology.

To fund respective tax and debt obligations created by options vesting, Managing Director and Chief Executive Officer, Dr. Phil Hodgson and Executive Director and Chief Scientist, Dr. Mark Sceats have sold approximately 4% of each of their shareholdings (A$2.4m in aggregate at the placement price of A$4.55 per share) in conjunction with the Placement.

Both Dr. Hodgson and Dr. Sceats remain fully committed to Calix. Updated 3Y change in director interest forms for Dr. Hodgson and Dr. Sceats follow this notice.

This announcement has been authorised for release to the ASX by:

Phil Hodgson Managing Director and CEO Calix Limited 9-11 Bridge Street Pymble NSW 2073 Ph +61 2 8199 7400

==> picture [596 x 68] intentionally omitted <==

About Calix

Calix is a team of dedicated people who are urgently developing great businesses, leveraging our patented technology, that deliver positive global impact.

The core technology is being used to develop more environmentally-friendly solutions for water treatment, CO2 mitigation, biotechnology, advanced batteries, and more sustainable mineral and chemical processing.

Calix develops its technology via a global network of research and development collaborations, including governments, research institutes and universities, some of world’s largest companies, and a growing customer base and distributor network for its commercialised products and processes.

Because there’s only one Earth – Mars is for Quitters.

Website: https://www.calix.global/ Twitter: @CalixLimited YouTube: CalixLimited

For more information: Phil Hodgson Darren Charles Managing Director and CEO CFO and Company Secretary [email protected] [email protected] +61 2 8199 7400 +61 2 8199 7400

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity – Calix Limited ABN – 36 117 372 540

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Dr. Philip Hargraves Hodgson
Date of last notice 13 October 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
-
Date of change 24/10/2022
No. of securities held prior to change
Pigeons Super Pty Limited Family A/C> (Director & beneficiary)
Pigeon
Investments
Pty
Ltd
Discretionary A/C> (Trustee & beneficiary)
Phil Hodgson
Dr Philip Hargraves Hodgson
2,188,280 Ordinary shares
800,024 Ordinary shares
1,106,925 Ordinary shares
1,239,383 Performance rights
Class Fully Priced Ordinary Shares
Number acquired -
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number disposed 193,407
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
$4.55 per ordinary share pursuant to an
off-market trade managed as part of the
Placement announced on 19 October
2022.
No. of securities held after change
Pigeons Super Pty Limited Family A/C> (Director & beneficiary)
Pigeon
Investments
Pty
Ltd
Discretionary A/C> (Trustee & beneficiary)
Phil Hodgson
Dr Philip Hargraves Hodgson
2,193,059 Ordinary shares
606,617 Ordinary shares
1,311,148 Ordinary shares
1,035,160 Performance rights
Nature of change
Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan, participation in
buy-back
193,407 sold pursuant to an off-market
trade as announcement on 19 October
2022 to fund tax and loan obligations.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract -
Nature of interest -
Name of registered holder
(if issued securities)
-
Date of change -
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
-
Interest acquired -
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Interest disposed -
Value/Consideration
Note: If consideration is non-cash, provide details
and an estimated valuation
-
Interest after change -

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed
above traded during a+closed period where prior written
clearance was required?
No
If so, was prior written clearance provided to allow the
trade to proceed during this period?
-
If prior written clearance was provided, on what date was
this provided?
-
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity – Calix Limited ABN – 36 117 372 540

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Dr. Mark Geoffrey Sceats
Date of last notice 10 November 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
-
Date of change 24/10/2022
No. of securities held prior to change
Direct
Mark Geoffrey Sceats
Indirect
Mark Geoffrey Sceats Fund> (Trustee & beneficiary)
Elizabeth Elenius (Spouse)
4,402,417 Ordinary shares
641,186 Unvested Performance rights
3,172,236 Ordinary shares
354,966 Ordinary shares
Class Fully Paid Ordinary Shares
Number acquired -
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number disposed 329,671
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
$4.55 per ordinary share pursuant to an
off-market trade managed as part of the
Placement announced on 19 October
2022.
No. of securities held after change
Mark Geoffrey Sceats
Mark Geoffrey Sceats Fund> (Trustee & beneficiary)
Elizabeth Elenius (Spouse)
4,402,417 Ordinary shares
641,186 Unvested Performance rights
2,847,344 Ordinary shares
404,466 Ordinary shares
Nature of change
Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan, participation in
buy-back
329,671 sold pursuant to an off-market
trade as announcement on 19 October
2022 to fund tax and loan obligations.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract -
Nature of interest -
Name of registered holder
(if issued securities)
-
Date of change -
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
-
Interest acquired -
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

  • Interest disposed Value/Consideration - Note: If consideration is non-cash, provide details and an estimated valuation - Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed
above traded during a+closed period where prior written
clearance was required?
No
If so, was prior written clearance provided to allow the
trade to proceed during this period?
-
If prior written clearance was provided, on what date was
this provided?
-
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3